MedTrace Logo

A Natural History Study of Participants With Potassium Sodium-Activated Channel Subfamily T Member 1 (KCNT1)-Related Epilepsy

NCT04924153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2024-02-28

No results posted yet for this study

Summary

The primary objective of the study is to characterize seizures in participants with KCNT1-related epilepsy. The secondary objectives are to characterize head growth, symptom severity, neurocognitive and social functions, adaptive behavior, sleep, quality of life, caregiver burden, and mood in participants with KCNT1-related epilepsy.

Conditions

  • KCNT1-Related Epilepsy

Interventions

OTHER

No Intervention

Administered as specified in the treatment arm.

Sponsors & Collaborators

  • David Bearden

    collaborator UNKNOWN

  • University of Rochester

    collaborator OTHER

  • Biogen

    lead INDUSTRY

Principal Investigators

  • Medical Director · Biogen

Eligibility

Min Age
0 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-17
Primary Completion
2023-08-29
Completion
2023-08-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04924153 on ClinicalTrials.gov